This new product will offer a much needed treatment option for patients suffering from this rare illness that, in some cases, has been found to progress to fatal forms of leukemia.
The doctors who perform approximately 2,200 heart transplants in the U.S. each year will now have a new option for enhancing successful outcomes.
Until today, patients with diabetes who need insulin to manage their disease had only one way to treat their condition. It is our hope that the availability of inhaled insulin will offer patients more options to better control their blood sugars.
It is our hope that the availability of inhaled insulin will offer patients more options to better control their blood sugars.